Document is current
Any future updates will be listed below
-
Authors
Yim, Aldrin K. Y.
Wang, Peter L.
Bermingham, John R. Jr https://orcid.org/0000-0003-4033-6011
Hackett, Amber
Strickland, Amy
Miller, Timothy M.
Ly, Cindy
Mitra, Robi D.
Milbrandt, Jeffrey https://orcid.org/0000-0002-5477-7689
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01NS078398, R01NS105645)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (RF1MH117070)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (R01AG013730)
- License Information
-
More Information
Article History
Received: 13 May 2021
Accepted: 14 December 2021
First Online: 3 February 2022
Competing interests
: J.M. is a cofounder, consultant and shareholder of Disarm Therapeutics, a wholly owned subsidiary of Eli Lilly & Company. All other authors declare no competing financial interests.
